Teva Pharmaceutical Industries recalls Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: T…

Recall date

October 20, 2015

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0521-2016

FDA classification

Class III

Brand / firm

Teva Pharmaceutical Industries

Sold / distributed

Nationwide

Why it was recalled

Labeling: Incorrect or Missing Lot AND/OR Exp Date.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel, Manufactured for: TEVA PHARMACEUTICAL INDUSTRIES USA Sellersville, PA 18960. NDC 0093-8238-98